PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2018.02820195111-11S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST TrialChoong-kun Lee, Minkyu Jung, Hyo Song Kim, Inkyung Jung, Dong Bok Shin, Seok Yun Kang, Dae Young Zang, Ki Hyang Kim, Moon Hee Lee, Bong-Seog Kim, Kyung Hee Lee, Jae-Ho Cheong, Woo Jin Hyung, Sung Hoon Noh, Hyun Cheol Chung, Sun Young Rhahttp://e-crt.org/upload/pdf/crt-2018-028.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2018.028, http://www.e-crt.org/upload/pdf/crt-2018-028.pdf
Lung Cancer10.1016/0169-5002(94)90399-91994111-2147-148Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer: Results of a randomized prospective studyhttps://api.elsevier.com/content/article/PII:0169500294903999?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0169500294903999?httpAccept=text/plain
Cancer Research and Treatment10.4143/crt.2004.36.2.1402004362140Randomized Phase III Trial of Cisplatin, Epirubicin, Leucovorin, 5-Fluorouracil (PELF) Combination versus 5-fluorouracil Alone as Adjuvant Chemotherapy in Curative Resected Stage III Gastric CancerJae Jin Lee, Si-Young Kim, Im sik Shin, Kyung Sam Cho, Hoong-Zae Joo, Choong Yoon, Yoon Wha Kim, Hwi Joong Yoonhttp://www.e-crt.org/upload/pdf/crt-36-140.pdf, http://www.e-crt.org/upload/pdf/crt-36-140.pdf
British Journal of Cancer10.1038/sj.bjc.660466620089981232-1238Cost-effectiveness of adjuvant chemotherapy with uracil–tegafur for curatively resected stage III rectal cancerA Hisashige, S Yoshida, S Kodairahttp://www.nature.com/articles/6604666.pdf, http://www.nature.com/articles/6604666, http://www.nature.com/articles/6604666.pdf
Frontiers in Medicine10.3389/fmed.2022.86177720229POF (paclitaxel/oxaliplatin/5-fluorouracil/leucovorin) vs. SOX/CAPOX/FOLFOX as a postoperative adjuvant chemotherapy for curatively resected stage III gastric cancer: Study protocol for a randomized controlled trial, FNF-014 trialLiyu Su, Shen Zhao, Yi Yin, Feng Huang, Jinfeng Zhu, Luchuan Chen, Rongbo Lin, https://www.frontiersin.org/articles/10.3389/fmed.2022.861777/full
Cancer10.1002/(sici)1097-0142(19981115)83:10<2054::aid-cncr2>3.0.co;2-1199883102054-2059OK-432 and 5-fluorouracil, doxorubicin, and mitomycin C (FAM-P) versus FAM chemotherapy in patients with curatively resected gastric carcinomaSi-Young Kim, Ho C. Park, Choong Yoon, Hwi J. Yoon, Yong M. Choi, Kyung S. Chohttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F(SICI)1097-0142(19981115)83:10%3C2054::AID-CNCR2%3E3.0.CO;2-1, https://onlinelibrary.wiley.com/doi/full/10.1002/(SICI)1097-0142(19981115)83:10%3C2054::AID-CNCR2%3E3.0.CO;2-1
Cancer Chemotherapy and Pharmacology10.1007/s00280-006-0315-5200658S143-48A randomized phase III trial of adjuvant treatment for resected non-small cell lung cancer in JapanYukito Ichinosehttp://link.springer.com/content/pdf/10.1007/s00280-006-0315-5.pdf, http://link.springer.com/article/10.1007/s00280-006-0315-5/fulltext.html, http://link.springer.com/content/pdf/10.1007/s00280-006-0315-5
Annals of Oncology10.1093/annonc/mdg1002003143395-3995-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer:long-term follow-up results of the adjCCA-01 trialH.T. Arkenau, A. Bermann, K. Rettig, G. Strohmeyer, R. Porschenhttps://api.elsevier.com/content/article/PII:S0923753419478290?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753419478290?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/14/3/395/554957/mdg100.pdf
Lung Cancer10.1016/0169-5002(91)91930-a19917155Surgical adjuvant chemotherapy in stage III Non-Small Cell Lung Cancer: Randomized controlled trialhttps://api.elsevier.com/content/article/PII:016950029191930A?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:016950029191930A?httpAccept=text/plain
Lung Cancer10.1016/0169-5002(95)99022-a1995123323A phase 3 randomized trial of immediate combination chemotherapy vs delayed combination chemotherapy in patients with completely resected stage II and III non-small cell carcinoma of the lunghttps://api.elsevier.com/content/article/PII:016950029599022A?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:016950029599022A?httpAccept=text/plain